Soliton Inc
NASDAQ:SOLY
Soliton Inc
NASDAQ:SOLY
Price:
22.58 USD
Market Closed
Updated:
May 4, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of SOLY.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SOLY
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
SOLY Competitors Multiples
Soliton Inc Competitors
Soliton Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Soliton Inc
NASDAQ:SOLY
|
487.6m USD | 1 318 | -27.3 | -20.1 | -19.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.5B USD | 4.6 | 32.6 | 19.2 | 28.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.1B USD | 18.5 | 68 | 55.8 | 69.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
124.8B USD | 6 | 37.1 | 24.1 | 29.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.5B USD | 3.4 | 25.8 | 13.8 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.2B USD | 7.2 | 60.2 | 30.7 | 45.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.7B USD | 3.5 | 55.6 | 18.6 | 39.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 2.7 | 38.1 | 18.3 | 30.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.6B USD | 8.4 | 36.5 | 26.5 | 28.7 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.9B USD | 13.4 | 79.6 | 59.5 | 77.4 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
